Areas of Specialization: behavioral and pharmacologic treatments for drug and alcohol dependence, clinical trials, co-occurring psychiatric disorders, mutual help
Since completing clinical training and coming to New Mexico in 1994, I have been blessed with many opportunities and the support of wonderful mentors and colleagues. I’ve done a lot of work to develop clinical and educational programs in Addiction Psychiatry at UNM. Recently I have devoted the majority of my effort to clinical research on the treatment of addictions. My goals for the next 5 years are to deepen my own program of clinical research in addictions and co-occurring disorders, and to facilitate the development of trainees and junior faculty in addictions treatment and research, and to promote the further growth of clinical research in all areas of psychiatry at UNM.
Geppert, C. M. A., Bogenschutz, M. P. (2009) Pharmacological Research on Addictions: A Framework for Ethical and Policy Considerations. Journal of Psychoactive Drugs 41 (1) 49-60.
Woody, G. E., Poole S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., Patkar, A., Publicker, M., McCain, K., Potter, J. S., Forman, R., Vetter, V., McNicholas, L., Blaine, J., Lynch, K. G., Fudala, P. (2008). Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial. JAMA 300, 2003-2011.
Bogenschutz, M. P., Tonigan, J. S., Pettinati, H.M. (2008) Effects of alcoholism typology on response to naltrexone in the COMBINE trial. Alcoholism: Clinical and Experimental Research 32 (12) 1-9.
Bogenschutz, M. P., DeMarzo, L, Roll, J. (2008). Response: anticipating new medications. Addiction Science & Clinical Practice 2 (4), 36-38.
Bogenschutz, M.P. (2007) 12-step approaches for the dually diagnosed: mechanisms of change. Alcoholism: Clinical and Experimental Research 31 (S3), 64S-66S.
Miller, W. R., Bogenschutz, M. P. (2007) Spirituality and Addiction. Southern Medical Journal 100 (4):433-436.
Geppert, C., Bogenschutz, M. P., Miller W. R. (2007) Development of a Bibliography on Spirituality and Addictions. Drug and Alcohol Review 26, 389-395.
Tonigan, J. S., Bogenschutz, M. P., & Miller, W. R. (2006). Is alcoholism typology a predictor of both AA affiliation and disaffiliation after treatment? Journal of Substance Abuse Treatment, 30, 323-330.
Bogenschutz, M. P., Tonigan, J. S., & Miller, W. R. (2006). Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change. Journal of Studies on Alcohol, 67, 562-567.
Miller, W.R, Bogenschutz, M. P., Villarreal, I. (2006). Research and practice together: The NIDA Clinical Trials Network. Adicciones 18 (1), 11-22.
Bogenschutz M. P., Geppert, C. M. A., George, J. (2006) The role of 12-step approaches in dual diagnosis treatment and recovery. American Journal on Addictions 15 (1), 50-60.
Current Grant Support
Clinical Trials Network:
Southwest Node (U10DA15833)
This grant supports the Node’s participation in the multi-site trials of the Clinical Trials Network.
· CTN 0010: Buprenorphine/Naloxone-Facilitated Rehabilitation For Opioid Dependent Adolescents/Young Adults
· CTN 0013: Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users
· CTN 0018 HIV/STD Safer Sex Skills Groups For Men In Methadone Maintenance Or Drug-Free Outpatient Treatment Programs
· CTN 0020 Job-Seekers Training for Patients with Drug Dependence
· CTN 0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse (METS)
· CTN 0032 Rapid HIV testing and counseling in drug abuse treatment programs in the US
· CTN 0033A Native American Methamphetamine and Other Drug Use and Treatment in the Southwest
A Program of Research and
Mentorship on Alcoholism and Co-occurring Disorders (K24AA016555)
This mid-career award supports the development of a new line of research involving co-administration of disulfiram and a benzodiazepine for individuals with alcohol dependence and co-occurring anxiety disorders. Specific Aims also include new mentorship activities and acquisition of new methodological skills.
12-step Facilitation for
the Dually Diagnosed (R01AA015419)Michael
P. Bogenschutz, P.I.